Abbassian Mehrdad MD Naperville, IL - 60563

Abbassian Mehrdad MD is categorized under Family Practice Doctors in Naperville, IL and active since 1991.

Abbassian Mehrdad MD was established in 1991, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Mehrdad Abbassian at the company’s single location by writing to 1327 Crystal Avenue, Naperville, Illinois IL 60563 or by phoning (630) 527-6320. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Abbassian Mehrdad MD
Contact Person: Mehrdad Abbassian
Address: 1327 Crystal Avenue, Naperville, Illinois 60563
Phone Number: (630) 527-6320
Website Address: advocatehealth.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1991
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Abbassian Mehrdad MD was started in 1991 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mehrdad Abbassian for inquiries that concern Abbassian Mehrdad MD by calling the company number (630) 527-6320, as your correspondence is most welcome. Additionally, the physical location of the single location of Abbassian Mehrdad MD can be found at the coordinates 41.79776,-88.18966 as well as the street address 1327 Crystal Avenue in Naperville, Illinois 60563.

For its online presence, you may visit Abbassian Mehrdad MD’s website at advocatehealth.com and engage with its social media outlets through on Twitter and on Facebook.